Cargando…
Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457027/ https://www.ncbi.nlm.nih.gov/pubmed/34553329 http://dx.doi.org/10.1007/s11845-021-02787-w |
| _version_ | 1784570992979345408 |
|---|---|
| author | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8457027 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84570272021-09-23 Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Ir J Med Sci Letter to the Editor Springer International Publishing 2021-09-22 2022 /pmc/articles/PMC8457027/ /pubmed/34553329 http://dx.doi.org/10.1007/s11845-021-02787-w Text en © The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic |
| title | Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic |
| title_full | Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic |
| title_fullStr | Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic |
| title_full_unstemmed | Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic |
| title_short | Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic |
| title_sort | use of aspirin for primary prevention in patients with diabetes during the covid-19 pandemic |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457027/ https://www.ncbi.nlm.nih.gov/pubmed/34553329 http://dx.doi.org/10.1007/s11845-021-02787-w |
| work_keys_str_mv | AT kowchiasiang useofaspirinforprimarypreventioninpatientswithdiabetesduringthecovid19pandemic AT ramachandramdineshsangarran useofaspirinforprimarypreventioninpatientswithdiabetesduringthecovid19pandemic AT hasansyedshahzad useofaspirinforprimarypreventioninpatientswithdiabetesduringthecovid19pandemic |